Differentiated Therapeutics

Differentiated Therapeutics

Edit info

  • Founded: 2021
  • Location: Boston, MA
  • Employee range: 1 - 10
  • Clinical stage: RD
  • Therapy area: Genetic diseases
  • Drug types: GEN
  • Lead product: Undisclosed
  • Funding: $5M seed Aug 2022


dxtherapeutics.com

linkedin.com

job board


Business:

Targeted Protein Degradation

About:

At Differentiated Therapeutics, founded in 2021, protein proximity is mapped in order to design disease-modifying degrader therapeutics for indications with high unmet clinical needs. Their proprietary AI-driven Auto/dx Platform allows the determination of genetically defined disease drivers that can be targeted with small molecule protein degraders for a wide array of diseases. Co-founders Bryce Allen, Isaac Kohane, and Diala Ezzeddine have expertise in Data Science, Biomedical Research, and Immuno-Oncology drug development.

Jobs:

Post a job

News:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com